Heart Failure with preserved Ejection Fraction (HFpEF) is a prevalent disease with considerable individual and societal burden. HFpEF patients often suffer from multiple pathological conditions thatcomplicate management and adversely affect outcome, including pulmonary hypertension and chronic obstructive pulmonary disease (COPD). To date, no treatment proved to be fully effective in reducing morbidity and mortality in HFpEF, possibly due to an incomplete understanding of the underlying molecular mechanisms.
SALA, VALENTINA;MARGARIA, JEAN PIERO;MURABITO, ALESSANDRA;Morello, Fulvio;GHIGO, Alessandra;HIRSCH, Emilio
File in questo prodotto:
Non ci sono file associati a questo prodotto.